Cargando…

Effect Modification by Baseline Mortality in the MORDOR Azithromycin Trial

We examined whether baseline mortality risk, as a function of child age and site, modified the azithromycin mortality-reduction effect in the Macrolide Oraux pour Réduire les Décès avec un Oeil sur la Résistance (MORDOR) clinical trial. We used the Cox proportional hazards model with an interaction...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oron, Assaf P., Burstein, Roy, Mercer, Laina D., Arzika, Ahmed M., Kalua, Khumbo, Mrango, Zakayo, West, Sheila K., Bailey, Robin L., Porco, Travis C., Lietman, Thomas M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470539/ https://www.ncbi.nlm.nih.gov/pubmed/30734696 http://dx.doi.org/10.4269/ajtmh.18-1004

Ejemplares similares

Mass Oral Azithromycin for Childhood Mortality: Timing of Death After Distribution in the MORDOR Trial
por: Porco, Travis C, et al.
Publicado: (2019)

Efficacy of Mass Azithromycin Distribution for Reducing Childhood Mortality Across Geographic Regions
por: Porco, Travis C., et al.
Publicado: (2020)

Biannual Treatment of Preschool Children with Single Dose Azithromycin to Reduce Mortality: Impact on Azithromycin Resistance in the MORDOR Trial in Tanzania
por: Bloch, Evan M., et al.
Publicado: (2020)

Effect of Mass Treatment with Azithromycin on Causes of Death in Children in Malawi: Secondary Analysis from the MORDOR Trial
por: Hart, John D., et al.
Publicado: (2020)

Cost-Effectiveness of Mass Treatment with Azithromycin for Reducing Child Mortality in Malawi: Secondary Analysis from the MORDOR Trial
por: Hart, John D., et al.
Publicado: (2020)

MORDOR II: Persistence of Benefit of Azithromycin for Childhood Mortality
por: Keenan, Jeremy D., et al.
Publicado: (2019)

Mass Azithromycin Distribution to Prevent Childhood Mortality: A Pooled Analysis of Cluster-Randomized Trials
por: Oldenburg, Catherine E., et al.
Publicado: (2019)

Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger
por: O’Brien, Kieran S., et al.
Publicado: (2020)

Mass azithromycin distribution for reducing childhood mortality in sub-Saharan Africa
por: Keenan, Jeremy D, et al.
Publicado: (2018)

Macrolide Resistance in MORDOR I: A Cluster-Randomized Trial in Niger
por: Doan, Thuy, et al.
Publicado: (2019)

Causes of death after biannual azithromycin treatment: A community-level randomized clinical trial
por: Bloch, Evan M., et al.
Publicado: (2021)

Impact of Biannual Azithromycin on Anemia in Preschool Children in Kilosa District, Tanzania: A Cluster-Randomized Clinical Trial
por: Bloch, Evan M., et al.
Publicado: (2020)

The impact on malaria of biannual treatment with azithromycin in children age less than 5 years: a prospective study
por: Bloch, Evan M., et al.
Publicado: (2019)

A Randomized Trial of Two Coverage Targets for Mass Treatment with Azithromycin for Trachoma
por: West, Sheila K., et al.
Publicado: (2013)

Safety of azithromycin in infants under six months of age in Niger: A community randomized trial
por: Oldenburg, Catherine E., et al.
Publicado: (2018)

Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial
por: Arzika, Ahmed M., et al.
Publicado: (2019)

Effects of Biannual Azithromycin Mass Drug Administration on Malaria in Malawian Children: A Cluster-Randomized Trial
por: Hart, John D., et al.
Publicado: (2020)

The efficacy of oral azithromycin in clearing ocular chlamydia: Mathematical modeling from a community-randomized trachoma trial
por: Liu, Fengchen, et al.
Publicado: (2014)

Effect of Mass Azithromycin Distributions on Childhood Growth in Niger: A Cluster-Randomized Trial
por: Arzika, Ahmed M., et al.
Publicado: (2021)

Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial
por: Keenan, Jeremy D, et al.
Publicado: (2020)

Does Mass Azithromycin Distribution Impact Child Growth and Nutrition in Niger? A Cluster-Randomized Trial
por: Amza, Abdou, et al.
Publicado: (2014)

Mass Azithromycin and Malaria Parasitemia in Niger: Results from a Community-Randomized Trial
por: O'Brien, Kieran S., et al.
Publicado: (2017)

A Cluster-Randomized Controlled Trial Evaluating the Effects of Mass Azithromycin Treatment on Growth and Nutrition in Niger
por: Amza, Abdou, et al.
Publicado: (2013)

Temporal Trends in Phenotypic Macrolide and Nonmacrolide Resistance for Streptococcus pneumoniae Nasopharyngeal Samples Up to 36 Months after Mass Azithromycin Administration in a Cluster-Randomized Trial in Niger
por: Hazel, Ashley, et al.
Publicado: (2023)

Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome in children: a randomized, controlled trial
por: Pickering, Harry, et al.
Publicado: (2022)

Effect of Biannual Mass Azithromycin Distributions to Preschool-Aged Children on Trachoma Prevalence in Niger: A Cluster Randomized Clinical Trial
por: Arzika, Ahmed M., et al.
Publicado: (2022)

Optimal Seasonal Timing of Oral Azithromycin for Malaria
por: Gao, Daozhou, et al.
Publicado: (2014)

Prevalence of nasopharyngeal Streptococcus pneumoniae carriage and resistance to macrolides in the setting of azithromycin mass drug administration: analysis from a cluster-randomised controlled trial in Malawi, 2015–17
por: Hart, John D, et al.
Publicado: (2022)

Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution
por: Godwin, William, et al.
Publicado: (2020)

Mass Azithromycin Distribution and Community Microbiome: A Cluster-Randomized Trial
por: Doan, Thuy, et al.
Publicado: (2018)

Biannual Administrations of Azithromycin and the Gastrointestinal Microbiome of Malawian Children: A Nested Cohort Study Within a Randomized Controlled Trial
por: Chaima, David, et al.
Publicado: (2022)

Erratum to: Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution
por: Godwin, William, et al.
Publicado: (2020)

Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger
por: Arzika, Ahmed M., et al.
Publicado: (2022)

Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial
por: Oldenburg, Catherine E., et al.
Publicado: (2019)

Reduction of Coronavirus Burden With Mass Azithromycin Distribution
por: Doan, Thuy, et al.
Publicado: (2020)

One round of azithromycin MDA adequate to interrupt transmission in districts with prevalence of trachomatous inflammation—follicular of 5.0-9.9%: Evidence from Malawi
por: Kalua, Khumbo, et al.
Publicado: (2018)

Optimizing the Number of Child Deaths Averted with Mass Azithromycin Distribution
por: Oldenburg, Catherine E., et al.
Publicado: (2020)

Selection of Macrolide and Non-Macrolide Resistance with Mass Azithromycin Distribution: A Community-Randomized Trial
por: Doan, Thuy, et al.
Publicado: (2020)

Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma
por: Amza, Abdou, et al.
Publicado: (2021)

Neonatal azithromycin administration for prevention of infant mortality
por: Oldenburg, Catherine E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ib0ahbj7v46jabmatc5i06aeli